The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain
Trial details
- Registry ID
- NCT06637527
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal PainNCT06637527 | OKYO | Phase 2 | Terminated | 2025-04-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |